Neurosoft Bioelectronics welcomes two leading advisors in neuro AI
Geneva, Switzerland, July 31 2025 - Neurosoft Bioelectronics SA, a Swiss company with a US presence in New York, developing scalable implantable brain-computer interfaces, is pleased to announce that Prof. Guillaume Lajoie and Prof. Martin Schrimpf have joined as scientific advisors to support the company’s strategy in neuro artificial intelligence and foundation brain modeling.
This strategic addition reinforces Neurosoft’s ambition to build a foundation model of the brain trained on large-scale brain recordings, enabled by the company’s soft and high-resolution electrodes that can safely and stably cover a large cortical surface.
Prof. Guillaume Lajoie is Associate Professor at the University of Montréal and a core academic member of Mila, the Quebec AI Institute. His research explores mathematical tools and algorithms for brainmachine interfaces, and contributes to the responsible use of AI in scientific and clinical contexts. He was a leading author of POYO, one of the first neuro foundation models designed to decode large-scale neural activity from spike-level data.
Prof. Martin Schrimpf is a tenure-track Assistant Professor at EPFL and leads the NeuroAI research group at the EPFL Neuro-X Institute. His work combines deep learning, neuroscience, and cognitive science to build artificial neural networks that reproduce the brain’s internal representations and align with human behavior. After completing his PhD at MIT, he contributed to landmark studies in vision and language, and is the founder of the Brain-Score.org benchmarking platform.
“As we advance our clinical studies, we are exploring how our scalable and high-quality brain recordings could enable the development of foundation models,” said Dr. Nicolas Vachicouras, CEO and Co-Founder of Neurosoft Bioelectronics. “Guillaume and Martin bring exceptional expertise at the intersection of neuroscience and AI. Their guidance will be key as we work toward better brain decoding, biomarker discovery, and ultimately a general-purpose model of human brain function and cognition.”
Switzerland is emerging as a leader in AI foundation model research. Its national supercomputing center in Lugano inaugurated the Alps supercomputer in 2024, now ranked among the fastest systems in the world. The system has already been used to train open-source large language models developed by EPFL in collaboration with ETH Zurich, the Swiss National Supercomputing Centre (CSCS), and the Swiss Data Science Center (SDSC). As a spin-off from EPFL, Neurosoft Bioelectronics benefits from Switzerland’s strong academic and AI ecosystem. This positions the company to bridge high-quality clinical brain data with advanced AI models, enabling next-generation brain computer interfaces.
